Amgen (AMGN) Gains Attention On Aging Treatments, Is The Upside Already Priced In?

Why Amgen Stock Is Back In Focus Amgen (AMGN) moved into the spotlight after its share price climbed sharply alongside growing attention on treatments for age related conditions in the U.S., putting its role in an aging society under closer investor scrutiny. Over the past few months, momentum around Amgen has picked up, with a 30 day share price return of 9.41% and a 90 day move of 15.22% helping lift the stock to US$412.84. The 1 year total shareholder return of 44.39% and 5 year total...